Antiretroviral Drug Formulations for Treatment of Children Exposed to Hiv/aids

The present disclosure provides fast disintegrating formulations for the treatment of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) in patients such as neonatal, perinatal and pediatric children. Neonatal and perinatal formulations provide for the prevention or reduction of incidence of mother to child transmission of HIV. Also provided are formulations and methods for treating pediatric children having HIV/AIDS. The orally administered fast disintegrating formulations are in granule and tablet form and are specially formulation for children to increase adherence to treatment protocols.

Patents:
US 20,110,117,193

Inventor(s): ADEYEYE MOJI C [US]; ESSEKU FREDRICK [US]; JOSHI ANAJALI [US]

Type of Offer: Licensing



« More Medical Patents

---